571 results on '"Pickering, Matthew C"'
Search Results
2. The genetics and epidemiology of N- and O-immunoglobulin A glycomics
3. V-210.1: Efficacy of 12-week pegcetacoplan in kidney transplant recipients with recurrent C3 glomerulopathy (C3G) or immune complex membranoproliferative glomerulonephritis (IC-MPGN).
4. DEVELOPING THERAPIES FOR C3G: REPORT OF THE KIDNEY HEALTH INITIATIVE C3G TRIAL ENDPOINTS WORK GROUP
5. Complement Terminal Pathway Activation and Intrarenal Immune Response in C3 Glomerulopathy
6. The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
7. Description and Cross-Sectional Analyses of 25,880 Adults and Children in the UK National Registry of Rare Kidney Diseases Cohort
8. Effects of rare kidney diseases on kidney failure: a longitudinal analysis of the UK National Registry of Rare Kidney Diseases (RaDaR) cohort
9. Efficacy and Safety of Pegcetacoplan in Kidney Transplant Recipients With Recurrent Complement 3 Glomerulopathy or Primary Immune Complex Membranoproliferative Glomerulonephritis
10. A novel mutation in EROS (CYBC1) causes chronic granulomatous disease
11. Membranoproliferative Glomerulonephritis and C3 Glomerulopathy in Children
12. Factor H related proteins modulate complement activation on kidney cells
13. Improving Clinical Trials for Anticomplement Therapies in Complement-Mediated Glomerulopathies: Report of a Scientific Workshop Sponsored by the National Kidney Foundation
14. Gain-of-function factor H–related 5 protein impairs glomerular complement regulation resulting in kidney damage
15. Multi-omics identify falling LRRC15 as a COVID-19 severity marker and persistent pro-thrombotic signals in convalescence
16. The Role of Complement in Kidney Disease: Conclusions From a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
17. Description and cross-sectional analyses of 25,880 adults and children in the UK National Registry of Rare Kidney Diseases cohort
18. Canonical and noncanonical functions of complement in systemic lupus erythematosus
19. WCN24-683 EFFICACY OF 12-WEEK PEGCETACOPLAN IN KIDNEY TRANSPLANT RECIPIENTS WITH RECURRENT C3 GLOMERULOPATHY (C3G) OR IMMUNE COMPLEX MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS (IC-MPGN)
20. Complement activation in IgA nephropathy
21. Complement activity is regulated in C3 glomerulopathy by IgG–factor H fusion proteins with and without properdin targeting domains
22. SARS-CoV-2 Antibody Point-of-Care Testing in Dialysis and Kidney Transplant Patients With COVID-19
23. Effects of rare kidney diseases on kidney failure: a longitudinal analysis of the UK National Registry of Rare Kidney Diseases (RaDaR) cohort
24. The genetics and epidemiology ofN-andO-IgA glycomics
25. Complement factor H-deficient mice develop spontaneous hepatic tumors
26. Factor H–Related Protein 1 Drives Disease Susceptibility and Prognosis in C3 Glomerulopathy
27. Type I interferons affect the metabolic fitness of CD8+ T cells from patients with systemic lupus erythematosus
28. Glomerular Complement Factor H–Related Protein 5 (FHR5) Is Highly Prevalent in C3 Glomerulopathy and Associated With Renal Impairment
29. The role of complement in IgA nephropathy
30. Membranoproliferative Glomerulonephritis and C3 Glomerulopathy in Children
31. Glomerular membrane attack complex is not a reliable marker of ongoing C5 activation in lupus nephritis
32. Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
33. Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
34. The complement system
35. Circulating complement factor H–related protein 5 levels contribute to development and progression of IgA nephropathy
36. Progressive IgA Nephropathy Is Associated With Low Circulating Mannan-Binding Lectin–Associated Serine Protease-3 (MASP-3) and Increased Glomerular Factor H–Related Protein-5 (FHR5) Deposition
37. Hyperfunctional complement C3 promotes C5-dependent atypical hemolytic uremic syndrome in mice
38. C3 glomerulopathy — understanding a rare complement-driven renal disease
39. Cell-autonomous regulation of complement C3 by factor H limits macrophage efferocytosis and exacerbates atherosclerosis
40. Membranoproliferative and C3-Mediated GN in Children
41. Circulating complement factor H–related proteins 1 and 5 correlate with disease activity in IgA nephropathy
42. Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference
43. Complement Factor H Inhibits CD47-Mediated Resolution of Inflammation
44. Autoantibody-dependent amplification of inflammation in SLE
45. 23 - Glomerulonephritis Associated With Complement Disorders
46. Factor H-related protein 1 drives disease susceptibility and prognosis in C3 glomerulopathy
47. Extracellular DNA and autoimmune diseases
48. Distinct roles for the complement regulators factor H and Crry in protection of the kidney from injury
49. Complement receptor 3 mediates renal protection in experimental C3 glomerulopathy
50. Complement Factor H Serum Levels Determine Resistance to Pneumococcal Invasive Disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.